MabPlex Overview

  • Year Founded
  • 2013

Year Founded

  • Status
  • Private

  • Employees
  • 667

Employees

  • Latest Deal Type
  • IPO
  • (Cancelled)

  • Investors
  • 19

MabPlex General Information

Description

Provider of contract development and manufacturing services intended to offer comprehensive services from drug development to drug manufacturing. The company offers contract services from DNA to finished drug product and manufactures monoclonal antibodies (MABs), recombinant proteins, Antibody drugs (ADCs) and bispecific, enabling customers to receive high quality solutions for bio-manufacturing.

Contact Information

Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Corporate Office
  • 60 Middle Beijing Road
  • Yantai Development Zone, Pilot Free Trade Zone
  • Yantai, Shandong 264006
  • China
+86 0535
Primary Industry
Other Pharmaceuticals and Biotechnology
Vertical(s)
Corporate Office
  • 60 Middle Beijing Road
  • Yantai Development Zone, Pilot Free Trade Zone
  • Yantai, Shandong 264006
  • China
+86 0535

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

MabPlex Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
6. IPO 16-Feb-2025 Cancelled Profitable
5. Secondary Transaction - Private 08-Jun-2020 Completed Generating Revenue
4. Later Stage VC (Series B) 01-Jun-2020 Completed Generating Revenue
3. Secondary Transaction - Private 29-May-2020 Completed Generating Revenue
2. Later Stage VC (Series A) 01-Nov-2018 $56.4M $56.4M Completed Generating Revenue
1. Joint Venture 25-Jun-2013 Completed Generating Revenue
To view MabPlex’s complete valuation and funding history, request access »

MabPlex Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last
Financing
Details
Provider of contract development and manufacturing services intended to offer comprehensive services from drug developme
Other Pharmaceuticals and Biotechnology
Yantai, China
667 As of 2022

Basel, Switzerland
 

Beijing, China
 
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

MabPlex Competitors (16)

One of MabPlex’s 16 competitors is Lonza Group, a Corporation company based in Basel, Switzerland.

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
Lonza Group Corporation Basel, Switzerland
Bellen Chemistry Venture Capital-Backed Beijing, China
KBI BioPharma Formerly VC-backed Durham, NC
AAPharmaSyn Corporation Ann Arbor, MI
Fujifilm Diosynth Biotechnologies Corporate Backed or Acquired College Station, TX
You’re viewing 5 of 16 competitors. Get the full list »

MabPlex Patents

MabPlex Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
US-20240408226-A1 Antibody drug conjugate intermediate containing sn38 and its preparation method Pending 02-Nov-2021
AU-2022383308-A1 Antibody-drug conjugate intermediate comprising sn38 and preparation method therefor Active 02-Nov-2021
AU-2022383308-B2 Antibody-drug conjugate intermediate comprising sn38 and preparation method therefor Active 02-Nov-2021
CA-3228214-A1 Antibody-drug conjugate intermediate comprising sn38 and preparation method therefor Pending 02-Nov-2021
EP-4201429-A1 Antibody-drug conjugate intermediate comprising sn38 and preparation method therefor Active 02-Nov-2021 A61K47/68037
To view MabPlex’s complete patent history, request access »

MabPlex Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

MabPlex Investors (19)

Investor Name Investor Type Holding Investor Since Participating Rounds
Tongji Innovation & Enterpreneurship Holdings Corporation Minority
China Merchants Securities Asset Manager Minority
Detong Capital Venture Capital Minority
Finnova Capital Venture Capital Minority
Gandao Investment Holding Company Asset Manager Minority
You’re viewing 5 of 19 investors. Get the full list »

MabPlex Investments (1)

MabPlex’s most recent deal was a Early Stage VC with CentryMed (Drug Discovery) for . The deal was made on 25-Sep-2020.

Company Name Deal Date Deal Type Deal Size Industry Lead Partner
CentryMed (Drug Discovery) 25-Sep-2020 Early Stage VC Drug Discovery
To view MabPlex’s complete investments history, request access »

MabPlex FAQs

  • When was MabPlex founded?

    MabPlex was founded in 2013.

  • Where is MabPlex headquartered?

    MabPlex is headquartered in Yantai, China.

  • What is the size of MabPlex?

    MabPlex has 667 total employees.

  • What industry is MabPlex in?

    MabPlex’s primary industry is Other Pharmaceuticals and Biotechnology.

  • Is MabPlex a private or public company?

    MabPlex is a Private company.

  • What is MabPlex’s current revenue?

    The current revenue for MabPlex is .

  • How much funding has MabPlex raised over time?

    MabPlex has raised $128M.

  • Who are MabPlex’s investors?

    Tongji Innovation & Enterpreneurship Holdings, China Merchants Securities, Detong Capital, Finnova Capital, and Gandao Investment Holding Company are 5 of 19 investors who have invested in MabPlex.

  • Who are MabPlex’s competitors?

    Lonza Group, Bellen Chemistry, KBI BioPharma, AAPharmaSyn, and Fujifilm Diosynth Biotechnologies are some of the 16 competitors of MabPlex.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process